Tower Research Capital (TRC)’s Enlivex Ltd ENLV Stock Holding History

Tower Research Capital (TRC)’s Portfolio ENLV Stock Details ENLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-192	Closed	-$2.68K	–	5334
2026 Q1	$2.68K	Buy	192 +43	+29%	+$681	﹤0.01%	4436
2025 Q4	$1.57K	Buy	+149	New	+$2.22K	﹤0.01%	4675
2022 Q1	–	Sell	-4	Closed	–	–	6192
2021 Q4	$0	Sell	4 -8	-67%	-$942	﹤0.01%	6235
2021 Q3	$2K	Buy	+12	New	+$1.76K	﹤0.01%	5252
2021 Q2	–	Sell	-166	Closed	-$28K	–	5553
2021 Q1	$28K	Buy	+166	New	+$34.2K	﹤0.01%	3605
2016 Q4	–	Hold	0	–	–	–	3950
2016 Q3	–	Hold	0	–	–	–	3818
2016 Q2	–	Hold	0	–	–	–	4543
2016 Q1	–	Sell	-3	Closed	-$5.34K	–	3672
2015 Q4	$6K	Buy	+3	New	+$8.46K	﹤0.01%	2752
2015 Q3	–	Hold	0	–	–	–	4185
2015 Q2	–	Sell	-1	Closed	-$3K	–	4523
2015 Q1	$3K	Hold	1	–	–	﹤0.01%	3550
2014 Q4	$6K	Hold	1	–	–	﹤0.01%	2578
2014 Q3	$2K	Buy	+1	New	+$4.89K	﹤0.01%	3794

Other funds holding ENLV

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tower Research Capital (TRC)'s ENLV Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Enlivex Ltd (ENLV) in Q2 2026, closing a stake of 192 shares — an estimated $2.68K sold.

Tower Research Capital (TRC) first reported a position in ENLV in Q3 2014 and held it in 9 quarters. The position peaked at $28K in Q1 2021. 24 funds tracked by Wall St. Rank hold ENLV as of Q2 2026.

Tower Research Capital (TRC) reported no remaining Enlivex Ltd position as of Q2 2026 after selling out during the quarter.
Tower Research Capital (TRC) sold 192 Enlivex Ltd shares in Q2 2026, an estimated $2.68K.
Tower Research Capital (TRC) first reported a position in Enlivex Ltd in Q3 2014 and held it in 9 quarters.
Tower Research Capital (TRC)'s Enlivex Ltd position peaked at $28K in Q1 2021.
24 funds tracked by Wall St. Rank held Enlivex Ltd as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.